Production of adenine nucleotide translocator (ant), novel ant lgands and screening assays therrfor
AssigneeMigenix Inc.
InventorsCHRISTEN M. ANDERSON, ROBERT E. DAVIS, WILLIAM CLEVENGER, SANDRA EILEEN WILEY, SCOTT W. MILLER, TOMAS R. SZABO, SOUMITRA S. GHOSH
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for producing adenine nucleotide translocator (ANT) polypeptides and fusion proteins, including the production and use of recombinant expression constructs having a regulated promoter. ANT ligands and compositions and methods for identifying ANT ligands, agents that bind ANT and agents that interact with ANT are also disclosed.
Claims101
A recombinant expression construct comprising at least one regulated promoter operably linked to a first nucleic acid encoding an adenine nucleotide translocator polypeptide.
A recombinant expression construct comprising at least one promoter operably linked to a nucleic acid molecule comprising a first nucleic acid sequence and a second nucleic acid sequence, said first nucleic acid sequence encoding an animal adenine nucleotide translocator polypeptide wherein the adenine nucleotide translocator polypeptide is expressed as a fusion protein with a polypeptide product of said second nucleic acid sequence.
A method of producing a recombinant adenine nucleotide translocator polypeptide, comprising:
- culturing a host cell comprising a recombinant expression construct comprising at least one regulated promoter operably linked to a first nucleic acid encoding an adenine nucleotide translocator polypeptide.
A method of producing a recombinant adenine nucleotide translocator polypeptide, comprising:
- culturing a host cell comprising a recombinant expression construct comprising at least one promoter operably linked to a nucleic acid molecule comprising a first nucleic acid sequence and a second nucleic acid sequence, said first nucleic acid sequence encoding an animal adenine nucleotide translocator polypeptide wherein the adenine nucleotide translocator polypeptide is expressed as a fusion protein with a polypeptide product of said second nucleic acid sequence.
An isolated human adenine nucleotide translocator polypeptide.
An isolated human adenine nucleotide translocator fusion protein comprising an adenine translocator polypeptide fused to at least one additional polypeptide sequence.
An isolated human adenine nucleotide translocator fusion protein comprising an adenine translocator polypeptide fused to at least one additional polypeptide sequence cleavable by a protease, said adenine nucleotide translocator polypeptide being separable from the fusion protein by cleavage with the protease.
An isolated adenine nucleotide translocator fusion protein comprising a first polypeptide that is an animal adenine translocator polypeptide fused to at least one additional polypeptide sequence.
An isolated recombinant animal adenine nucleotide translocator fusion protein comprising an adenine translocator polypeptide fused to at least one additional polypeptide sequence cleavable by a protease, said adenine nucleotide translocator polypeptide being separable from the fusion protein by cleavage with the protease.
A method for determining the presence of an ANT polypeptide in a biological sample comprising:
- contacting a biological sample suspected of containing an ANT polypeptide with an ANT ligand under conditions and for a time sufficient to allow binding of the ANT ligand to an ANT polypeptide;
- and
- detecting the binding of the ANT ligand to an ANT polypeptide, and therefrom determining the presence of an ANT polypeptide in said biological sample.
A method for isolating ANT from a biological sample, comprising:
- contacting a biological sample suspected of containing an ANT polypeptide with an ANT ligand under conditions and for a time sufficient to allow binding of the ANT ligand to an ANT polypeptide;
- and
- recovering the ANT polypeptide, and thereby isolating ANT from a biological sample.
A method for identifying an agent that binds to an ANT polypeptide, comprising:
- contacting a candidate agent with a host cell expressing at least one recombinant ANT polypeptide under conditions and for a time sufficient to permit binding of the agent to said recombinant ANT polypeptide;
- and
- detecting binding of said agent to the recombinant ANT.
A method for identifying an agent that binds to an ANT polypeptide, comprising:
- contacting a candidate agent with a biological sample containing at least one recombinant ANT polypeptide under conditions and for a time sufficient to permit binding of the agent to said ANT polypeptide;
- and
- detecting binding of said agent to the recombinant ANT polypeptide.
A method for identifying an agent that interacts with an ANT polypeptide comprising:
- contacting a biological sample containing recombinant ANT with a detectable ANT ligand in the presence of a candidate agent;
- and
- comparing binding of the detectable ANT ligand to recombinant ANT in the absence of said agent to binding of the detectable ANT ligand to recombinant ANT in the presence of said agent, and therefrom identifying an agent that interacts with an ANT polypeptide.
An ANT ligand comprising atractyloside substituted at the 6′ hydroxyl to form an atractyloside derivative.
An assay plate for high throughput screening of candidate agents that bind to at least one ANT polypeptide, comprising:
- an assay plate having a plurality of wells, each of said wells further comprising at least one immobilized recombinant ANT polypeptide or a variant or fragment thereof.
A method of targeting a polypeptide of interest to a mitochondrial membrane, comprising:
- expressing a recombinant expression construct encoding a fusion protein in a host cell, said construct comprising at least one regulated promoter operably linked to a nucleic acid molecule comprising a first nucleic acid sequence and a second nucleic acid sequence, said first nucleic acid sequence encoding an adenine nucleotide translocator polypeptide that is expressed as a fusion protein with a polypeptide product of said second nucleic acid sequence, wherein said second nucleic acid sequence encodes the polypeptide of interest.
A method of targeting a polypeptide of interest to a mitochondrial membrane, comprising:
- expressing a recombinant expression construct encoding a fusion protein in a host cell, said construct comprising at least one promoter operably linked to a nucleic acid molecule comprising a first nucleic acid sequence and a second nucleic acid sequence, said first nucleic acid sequence encoding an animal adenine nucleotide translocator polypeptide that is expressed as a fusion protein with a polypeptide product of said second nucleic acid sequence, wherein said second nucleic acid sequence encodes the polypeptide of interest.
Dependencies are inferred from the claim text.